Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shyreen Hassibi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Results and Problems in Cell Differentiation|October 15, 2024
Macrophage Dysfunction in Respiratory DiseaseShyreen Hassibi, Louise E Donnelly
Frontiers in Medicine|May 13, 2025
Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure miceJonathan R Baker, Leah Daly, Shyreen Hassibi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 30, 2018
MicroRNA-570 is a novel regulator of cellular senescence and inflammagingJonathan R Baker, Chaitanya Vuppusetty, Thomas Colley, et al.
Frontiers in Immunology|November 9, 2023
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signalingSean P Giblin, Sashini Ranawana, Shyreen Hassibi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Results and Problems in Cell Differentiation|October 15, 2024
Macrophage Dysfunction in Respiratory DiseaseShyreen Hassibi, Louise E Donnelly
Frontiers in Medicine|May 13, 2025
Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure miceJonathan R Baker, Leah Daly, Shyreen Hassibi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 30, 2018
MicroRNA-570 is a novel regulator of cellular senescence and inflammagingJonathan R Baker, Chaitanya Vuppusetty, Thomas Colley, et al.
Frontiers in Immunology|November 9, 2023
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signalingSean P Giblin, Sashini Ranawana, Shyreen Hassibi, et al.
Pageof 1